Oklahoma 2023 2023 Regular Session

Oklahoma Senate Bill SB711 Introduced / Bill

Filed 01/18/2023

                     
 
 
Req. No. 1392 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
SENATE BILL 711 	By: Rosino 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to substance abuse services; 
requiring the Department of Mental Health and 
Substance Abuse Services to provide opioid 
antagonists to the Department of Corrections and 
county jails; requiring the Department of Mental 
Health and Substance Abuse Services to prepare and 
provide opioid overdose education program ; describing 
program; amending 57 O.S. 2021, Section 4.1 , which 
relates to prisons and reformatories; requiring the 
Department of Corrections and county jails to provide 
opioid antagonists to certain persons upon discharge 
subject to certain condition; authorizing stocking 
and provision of opio id antagonists; requiring 
provision of opioid overdose education program to 
certain persons; providing certain construction; 
providing for codific ation; and providing an 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE S TATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 3-705 of Title 43A, unless there 
is created a duplication i n numbering, reads as follo ws: 
A.  The Department of Mental Health and Substance Abuse Services 
shall provide opioid antagonists to the Department of Corrections   
 
 
Req. No. 1392 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
and to county jails for the purpose of implementing Section 2 of 
this act. 
B.  The Department of Mental Health and Substance Abuse Services 
shall prepare and provide an opioid overd ose education program to 
the Department of Corrections and to county jails for the purpose of 
implementing Section 2 of this act.  The education program shall: 
1.  Conform to guidelines of the Substance Abuse and Mental 
Health Services Administration for opioid overdose education ; 
2. Explain the causes of an opioid overdose; 
3.  Instruct when and how to administer in accordance with 
medical best practices: 
a. life-saving rescue techniques , and 
b. an opioid antagonist; 
4.  Explain how to contact appropriate emergency medical 
services; and 
5.  Provide information on how to access opioid antagonists. 
SECTION 2.     AMENDATORY     57 O.S. 2021, Section 4.1, is 
amended to read as follo ws: 
Section 4.1. A. In addition to other medical and health care 
services required by a jail facility as may be provide d by rule by 
the State Department of Health, the person responsible for 
administration for a jail shall administer medi cations according to 
the following:   
 
 
Req. No. 1392 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  Prescription medications shall be provided to the prisoner 
as directed by a physician or designat ed medical authority.  The 
prisoner shall be observed to ensure the prisoner takes the 
medication. The physician or designated medical authority shall be 
particularly aware through his or her training of the impact of 
opiate or methadone withdrawal sympto ms that may occur in regard to 
the mental and physical health of the prisoner.  The physician or 
medical authority shal l prescribe and administer appropriate 
medications to the prisoner pursuant to Section 5 -204 of Title 43A 
of the Oklahoma Statutes as the medical authority deems appropriate 
to address those symptoms.  Neither prescription nor over -the-
counter medications shall be kept by a prisoner in a cell with the 
exception of prescribed nitroglycerin tablets and prescri ption 
inhalers.  Over-the-counter medications shall not be administered 
without a physician’s approval unless using prepackaged med ications; 
2.  Medical reception information shall be recorded on a printed 
screening form approved by the physician or design ated medical 
authority which shal l include inquiry into: 
a. current illnesses and health problems including 
medications taken and a ny special health req uirements, 
b. behavioral observation, including state of 
consciousness and mental status, 
c. body deformities and trauma markings such as bruises, 
lesions, jaundice, and ease of body movement,   
 
 
Req. No. 1392 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
d. condition of skin and visible body orif ices, including 
infestations, and 
e. disposition or referral of prisoners to qualified 
medical personnel on an emergency basi s; and 
3.  For purposes of this s ection, “physician or other licensed 
medical personnel” means a psychiatrist, medical doctor, oste opathic 
physician, physician’s assistant, registered nurse, licensed 
practical nurse, emergency medical technician at the par amedical 
level or clinical nurse specialist. 
B. 1. Subject to the provision of opioid antagonists by the 
Department of Mental Hea lth and Substance Abuse Services as provided 
by Section 1 of this act: 
a. the Department of Corrections, upon the discharge o f 
an inmate from an institution within the Department 
who has been diagnosed with an opioid use disorder , 
regardless of whether tha t inmate has received 
treatment for the disorder, shall provide the inmate , 
as the inmate leaves the institution, with two doses 
of an opioid antagonist , and 
b. a county jail: 
(1) upon the discharge of any person who is confined 
in the jail pursuant to a sentence who has been 
diagnosed with an opioid use disorder , regardless   
 
 
Req. No. 1392 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
of whether that person has received treatment for 
the disorder, or 
(2) upon the discharge of any person who is confined 
in the jail for an offense related to possession 
of an opioid drug other than: 
(a) a person who is confined in the jail 
pursuant to a sentence, or 
(b) a person who is being transferred to th e 
custody of the Department of Co rrections, 
 shall provide the person, as the person leaves the 
jail, with two doses of an opioid antagonist. 
2.  Notwithstanding the provision of opioid antagonists by the 
Department of Mental Health and Substance Abuse Ser vices as provided 
by Section 1 of this act, the Department of Corrections and county 
jails may stock and provide opioid antagonists to inmates or persons 
upon discharge from the institution or jail as described in 
paragraph 1 of this subsection. 
3.  Before the Department of Corrections or a county jail 
provides an opioid antagonist to a n inmate or person as described in 
paragraph 1 or 2 of this subsection, the Department or the jail 
shall ensure that the in mate or person is provided with the opioid 
overdose education program provided by the Department of Mental 
Health and Substance Abuse Services under Section 1 of this act.   
 
 
Req. No. 1392 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
4. Nothing in this subsection is intended to abro gate or 
supersede any existing authority of the Department of Corrections or 
a county jail to administer an opioid ant agonist to a person 
experiencing an opioid overdose. 
SECTION 3.  This act shall become effective November 1, 2023. 
 
59-1-1392 DC 1/18/2023 2:39:14 PM